Tanja Schirmeister

InstitutionUniversity of Mainz
AddressGermany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 1 publications in Spetember 2020 and October 2020 and March 2021 and May 2021 and January 2022
    All Publications
    Bar chart showing 108 publications over 20 distinct years, with a maximum of 13 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Müller P, Maus H, Hammerschmidt SJ, Knaff PM, Mailänder V, Schirmeister T, Kersten C. Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy. Curr Med Chem. 2022; 29(4):635-665. PMID: 34042026.
      Citations:    Fields:    
    2. Hammerschmidt SJ, Müller P, Schirmeister T. Biospektrum (Heidelb). 2021; 27(3):254-256. PMID: 33994673.
      Citations:    
    3. Amendola G, Ettari R, Previti S, Di Chio C, Messere A, Di Maro S, Hammerschmidt SJ, Zimmer C, Zimmermann RA, Schirmeister T, Zappalà M, Cosconati S. Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening. J Chem Inf Model. 2021 04 26; 61(4):2062-2073. PMID: 33784094.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    4. Welker A, Kersten C, Müller C, Madhugiri R, Zimmer C, Müller P, Zimmermann R, Hammerschmidt S, Maus H, Ziebuhr J, Sotriffer C, Schirmeister T. Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2. ChemMedChem. 2021 01 19; 16(2):340-354. PMID: 32930481.
      Citations: 5     Fields:    Translation:AnimalsCells
    5. Barthels F, Schirmeister T, Kersten C. BAN?IT: B'-Factor Analysis for Drug Design and Structural Biology. Mol Inform. 2021 01; 40(1):e2000144. PMID: 32830452.
      Citations:    Fields:    Translation:Humans
    6. Paasche A, Zipper A, Schäfer S, Ziebuhr J, Schirmeister T, Engels B. Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease. Biochemistry. 2014 Sep 23; 53(37):5930-46. PMID: 25196915.
      Citations: 36     Fields:    Translation:Cells
    7. Paasche A, Schirmeister T, Engels B. Benchmark Study for the Cysteine-Histidine Proton Transfer Reaction in a Protein Environment: Gas Phase, COSMO, QM/MM Approaches. J Chem Theory Comput. 2013 Mar 12; 9(3):1765-77. PMID: 26587634.
      Citations: 8     Fields:    
    8. Pimentel-Elardo SM, Buback V, Gulder TA, Bugni TS, Reppart J, Bringmann G, Ireland CM, Schirmeister T, Hentschel U. New tetromycin derivatives with anti-trypanosomal and protease inhibitory activities. Mar Drugs. 2011; 9(10):1682-97. PMID: 22072992.
      Citations: 7     Fields:    Translation:AnimalsCells
    9. Paasche A, Schiller M, Schirmeister T, Engels B. Mechanistic study of the reaction of thiol-containing enzymes with alpha,beta-unsaturated carbonyl substrates by computation and chemoassays. ChemMedChem. 2010 Jun 07; 5(6):869-80. PMID: 20401893.
      Citations: 6     Fields:    
    10. Kaeppler U, Stiefl N, Schiller M, Vicik R, Breuning A, Schmitz W, Rupprecht D, Schmuck C, Baumann K, Ziebuhr J, Schirmeister T. A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods. J Med Chem. 2005 Nov 03; 48(22):6832-42. PMID: 16250642.
      Citations: 25     Fields:    Translation:Cells
    11. Martina E, Stiefl N, Degel B, Schulz F, Breuning A, Schiller M, Vicik R, Baumann K, Ziebuhr J, Schirmeister T. Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor. Bioorg Med Chem Lett. 2005 Dec 15; 15(24):5365-9. PMID: 16216498.
      Citations: 7     Fields:    Translation:HumansCells